BCRX
BioCryst Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.31 / 10
Underperform
The fundamental analysis reveals a distressed profile: key metrics such as Net profit / Total profit (%) score poorly, while Asset-MV and Profit-MV are negative, indicating limited earnings power and asset efficiency. Only a few factors like PB-ROE and Gross profit margin (%) show partial strength, but they are insufficient to offset the weaknesses, leading to an overall negative assessment and an Underperform rating.
Analysis Checks(6/10)
Revenue-MV
Value-0.27
Score1/3
Weight15.68%
1M Return5.20%
Value-0.27
Score1/3
Weight15.68%
1M Return5.20%
Gross profit margin (%)
Value97.96
Score2/3
Weight3.88%
1M Return1.47%
Value97.96
Score2/3
Weight3.88%
1M Return1.47%
PB-ROE
Value2.51
Score2/3
Weight32.96%
1M Return10.68%
Value2.51
Score2/3
Weight32.96%
1M Return10.68%
Fixed assets turnover ratio
Value24.00
Score2/3
Weight0.31%
1M Return0.12%
Value24.00
Score2/3
Weight0.31%
1M Return0.12%
Cash-MV
Value-0.15
Score2/3
Weight23.51%
1M Return7.73%
Value-0.15
Score2/3
Weight23.51%
1M Return7.73%
Inventory turnover ratio
Value1.43
Score2/3
Weight-5.95%
1M Return-2.63%
Value1.43
Score2/3
Weight-5.95%
1M Return-2.63%
Profit-MV
Value-0.67
Score2/3
Weight23.48%
1M Return7.79%
Value-0.67
Score2/3
Weight23.48%
1M Return7.79%
Current assets turnover ratio
Value1.20
Score1/3
Weight-1.18%
1M Return-0.48%
Value1.20
Score1/3
Weight-1.18%
1M Return-0.48%
Asset-MV
Value-0.50
Score0/3
Weight8.02%
1M Return2.94%
Value-0.50
Score0/3
Weight8.02%
1M Return2.94%
Net profit / Total profit (%)
Value92.99
Score0/3
Weight-0.69%
1M Return-0.30%
Value92.99
Score0/3
Weight-0.69%
1M Return-0.30%
Revenue-MV
Value-0.27
Score1/3
Weight15.68%
1M Return5.20%
Value-0.27
Score1/3
Weight15.68%
1M Return5.20%
Inventory turnover ratio
Value1.43
Score2/3
Weight-5.95%
1M Return-2.63%
Value1.43
Score2/3
Weight-5.95%
1M Return-2.63%
Gross profit margin (%)
Value97.96
Score2/3
Weight3.88%
1M Return1.47%
Value97.96
Score2/3
Weight3.88%
1M Return1.47%
Profit-MV
Value-0.67
Score2/3
Weight23.48%
1M Return7.79%
Value-0.67
Score2/3
Weight23.48%
1M Return7.79%
PB-ROE
Value2.51
Score2/3
Weight32.96%
1M Return10.68%
Value2.51
Score2/3
Weight32.96%
1M Return10.68%
Current assets turnover ratio
Value1.20
Score1/3
Weight-1.18%
1M Return-0.48%
Value1.20
Score1/3
Weight-1.18%
1M Return-0.48%
Fixed assets turnover ratio
Value24.00
Score2/3
Weight0.31%
1M Return0.12%
Value24.00
Score2/3
Weight0.31%
1M Return0.12%
Asset-MV
Value-0.50
Score0/3
Weight8.02%
1M Return2.94%
Value-0.50
Score0/3
Weight8.02%
1M Return2.94%
Cash-MV
Value-0.15
Score2/3
Weight23.51%
1M Return7.73%
Value-0.15
Score2/3
Weight23.51%
1M Return7.73%
Net profit / Total profit (%)
Value92.99
Score0/3
Weight-0.69%
1M Return-0.30%
Value92.99
Score0/3
Weight-0.69%
1M Return-0.30%
Is BCRX undervalued or overvalued?
- BCRX scores 2.31/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -1.46% net margin, -180.26 P/E ratio, -4.08 P/B ratio, and 93.44% earnings growth, these metrics solidify its Underperform investment rating.
